Latest News and Press Releases
Want to stay updated on the latest news?
-
Roissy, 24 May 2022 Air France-KLM launches a €2.256 billion rights issue to be subscribed in cash and/or by offsetting claims The Company is continuing to strengthen its balance sheet and...
-
Did you lose money on investments in Pegasystems? If so, please visit Pegasystems Inc. Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or pallocco@bernlieb.com to discuss...
-
Did you lose money on investments in Okta? If so, please visit Okta Inc. Shareholder Class Action Lawsuit or contact Joe Seidman at (212) 951-2025 or seidman@bernlieb.com to discuss your rights. NEW...
-
BOUSSARD & GAVAUDAN HOLDING LIMITED Ordinary Shares The Directors of Boussard & Gavaudan Holding Limited would like to announce the following...
-
BOUSSARD & GAVAUDAN HOLDING LIMITED Ordinary Shares The Directors of Boussard & Gavaudan Holding Limited would like to announce the following...
-
紐約, May 24, 2022 (GLOBE NEWSWIRE) -- 為何:全球投資者權益律師事務所 Rosen Law Firm 提醒下述情況的 Arqit Quantum Inc. 原名 Centricus Acquisition Corp. (NASDAQ: ARQQ, ARQQW, CENH, CENHU, CENHW) 證券購買者:(i)在 2021 年 9 月 7 日至...
-
FRONTLINE LTD. REPORTS RESULTS FOR THE FIRST QUARTER ENDED MARCH 31, 2022 Frontline Ltd. (the “Company” or “Frontline”), today reported unaudited results for the three months ended...
-
Q1 2022 results performance in line with Q4 trends, with Core markets revenues up 7% year-on-year and Group EBITDA margin up 70 basis points vs. Q4 2021Portfolio optimisation progressing at pace, with...
-
24 May 2022 PayPoint plc ("the Company") As a result of transactions on 23th May 2022 by the PayPoint plc Share Incentive Plan (a HM Revenue & Customs approved all employee share purchase plan),...
-
Pivotal data on glofitamab, a potential first-in-class CD20xCD3 T-cell engaging bispecific antibody, in heavily pre-treated patients with aggressive lymphoma, will be presented as part of our...